Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Eigendorff

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Der Pathologe|August 29, 2015
[Acute leukemia in adults]E Eigendorff, A Hochhaus
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|August 16, 2017
Cementless Total Hip Arthroplasty in Primary Myelofibrosis - a Case ReportS Brodt, E Eigendorff, G Matziolis
Der Internist|April 11, 2015
[Chronic myelogenous leukemia]A Hochhaus, P La Rosée, E Eigendorff, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 7, 2010
In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acidS Diederich, M Quinkler, K Mai, et al.
The Journal of Endocrinology|January 30, 2003
Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pigM Quinkler, H Troeger, E Eigendorff, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 9, 2004
Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenasesS Diederich, T Scholz, E Eigendorff, et al.
Leukemia|September 13, 2014
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL statusM Schmidt, J Rinke, V Schäfer, et al.
Leukemia|February 26, 2015
Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemiaA Burchert, S Saussele, E Eigendorff, et al.
Leukemia|January 12, 2017
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CMLC Schütz, S Inselmann, S Saussele, et al.
Leukemia|January 31, 2018
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CMLC Schütz, S Inselmann, S Saussele, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Der Pathologe|August 29, 2015
[Acute leukemia in adults]E Eigendorff, A Hochhaus
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|August 16, 2017
Cementless Total Hip Arthroplasty in Primary Myelofibrosis - a Case ReportS Brodt, E Eigendorff, G Matziolis
Der Internist|April 11, 2015
[Chronic myelogenous leukemia]A Hochhaus, P La Rosée, E Eigendorff, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 7, 2010
In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acidS Diederich, M Quinkler, K Mai, et al.
The Journal of Endocrinology|January 30, 2003
Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pigM Quinkler, H Troeger, E Eigendorff, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 9, 2004
Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenasesS Diederich, T Scholz, E Eigendorff, et al.
Leukemia|September 13, 2014
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL statusM Schmidt, J Rinke, V Schäfer, et al.
Leukemia|February 26, 2015
Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemiaA Burchert, S Saussele, E Eigendorff, et al.
Leukemia|January 12, 2017
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CMLC Schütz, S Inselmann, S Saussele, et al.
Leukemia|January 31, 2018
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CMLC Schütz, S Inselmann, S Saussele, et al.
Pageof 1